Shoker Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.44M | Sell |
28,572
-887
| -3% | -$102K | 1.02% | 24 |
|
|
2025
Q4 | $3.1M | Buy |
29,459
+491
| +2% | +$46.1K | 0.91% | 31 |
|
|
2025
Q3 | $2.43M | Buy |
28,968
+285
| +1% | +$23.5K | 0.72% | 42 |
|
|
2025
Q2 | $2.27M | Buy |
28,683
+932
| +3% | +$74.1K | 0.71% | 43 |
|
|
2025
Q1 | $2.49M | Buy |
27,751
+716
| +3% | +$66.8K | 0.84% | 43 |
|
|
2024
Q4 | $2.69M | Buy |
27,035
+364
| +1% | +$37.5K | 0.91% | 35 |
|
|
2024
Q3 | $3.03M | Sell |
26,671
-799
| -3% | -$94.9K | 1.02% | 33 |
|
|
2024
Q2 | $3.4M | Sell |
27,470
-1,234
| -4% | -$159K | 1.2% | 24 |
|
|
2024
Q1 | $3.76M | Buy |
28,704
+52
| +0.2% | +$6.41K | 1.34% | 19 |
|
|
2023
Q4 | $3.12M | Buy |
28,652
+400
| +1% | +$41.5K | 1.21% | 20 |
|
|
2023
Q3 | $2.91M | Sell |
28,252
-358
| -1% | -$38.6K | 1.26% | 22 |
|
|
2023
Q2 | $3.3M | Sell |
28,610
-207
| -0.7% | -$23.5K | 1.38% | 19 |
|
|
2023
Q1 | $3.07M | Sell |
28,817
-293
| -1% | -$31.6K | 1.34% | 21 |
|
|
2022
Q4 | $3.23M | Buy |
29,110
+407
| +1% | +$41.6K | 1.45% | 18 |
|
|
2022
Q3 | $2.47M | Buy |
28,703
+1,237
| +5% | +$110K | 1.3% | 24 |
|
|
2022
Q2 | $2.5M | Buy |
27,466
+1,136
| +4% | +$101K | 1.33% | 27 |
|
|
2022
Q1 | $2.16M | Buy |
26,330
+172
| +0.7% | +$13.6K | 1.07% | 34 |
|
|
2021
Q4 | $2M | Sell |
26,158
-49
| -0.2% | -$3.9K | 0.92% | 35 |
|
|
2021
Q3 | $1.97M | Buy |
26,207
+1,187
| +5% | +$90.3K | 0.98% | 33 |
|
|
2021
Q2 | $1.95M | Sell |
25,020
-705
| -3% | -$52.4K | 0.97% | 30 |
|
|
2021
Q1 | $1.89M | Sell |
25,725
-125
| -0.5% | -$9.22K | 0.99% | 31 |
|
|
2020
Q4 | $2.02M | Buy |
25,850
+240
| +0.9% | +$18.4K | 1.13% | 26 |
|
|
2020
Q3 | $2.03M | Buy |
25,610
+116
| +0.5% | +$9.09K | 1.33% | 22 |
|
|
2020
Q2 | $1.88M | Buy |
25,494
+259
| +1% | +$19.5K | 1.31% | 23 |
|
|
2020
Q1 | $1.85M | Buy |
25,235
+2,147
| +9% | +$169K | 1.56% | 21 |
|
|
2019
Q4 | $2M | Buy |
23,088
+437
| +2% | +$35.9K | 1.33% | 23 |
|
|
2019
Q3 | $1.82M | Buy |
22,651
+237
| +1% | +$19K | 1.31% | 25 |
|
|
2019
Q2 | $1.79M | Sell |
22,414
-356
| -2% | -$27.3K | 1.31% | 26 |
|
|
2019
Q1 | $1.81M | Buy |
22,770
+212
| +0.9% | +$15.9K | 1.33% | 23 |
|
|
2018
Q4 | $1.64M | Sell |
22,558
-167
| -0.7% | -$11.8K | 1.38% | 20 |
|
|
2018
Q3 | $1.54M | Buy |
22,725
+315
| +1% | +$20.1K | 1.12% | 25 |
|
|
2018
Q2 | $1.3M | Buy |
22,410
+81
| +0.4% | +$4.57K | 0.97% | 31 |
|
|
2018
Q1 | $1.16M | Buy |
22,329
+160
| +0.7% | +$8.64K | 0.88% | 34 |
|
|
2017
Q4 | $1.19M | Buy |
22,169
+206
| +0.9% | +$11.4K | 0.86% | 34 |
|
|
2017
Q3 | $1.34M | Sell |
21,963
-328
| -1% | -$19.9K | 1.02% | 31 |
|
|
2017
Q2 | $1.36M | Buy |
22,291
+1,193
| +6% | +$72.6K | 1.07% | 30 |
|
|
2017
Q1 | $1.28M | Sell |
21,098
-1,361
| -6% | -$82.6K | 1.07% | 28 |
|
|
2016
Q4 | $1.26M | Buy |
22,459
+74
| +0.3% | +$4.33K | 1.04% | 31 |
|
|
2016
Q3 | $1.33M | Buy |
22,385
+100
| +0.4% | +$5.85K | 1.13% | 26 |
|
|
2016
Q2 | $1.23M | Buy |
22,285
+45
| +0.2% | +$2.4K | 1.09% | 30 |
|
|
2016
Q1 | $1.12M | Buy |
22,240
+1,851
| +9% | +$90.7K | 1.06% | 32 |
|
|
2015
Q4 | $1.03M | Buy |
20,389
+126
| +0.6% | +$6.35K | 1.03% | 32 |
|
|
2015
Q3 | $954K | Sell |
20,263
-318
| -2% | -$16.9K | 1.01% | 34 |
|
|
2015
Q2 | $1.12M | Sell |
20,581
-382
| -2% | -$21.4K | 1.05% | 30 |
|
|
2015
Q1 | $1.15M | Buy |
20,963
+366
| +2% | +$20.7K | 1.09% | 30 |
|
|
2014
Q4 | $1.12M | Sell |
20,597
-106
| -0.5% | -$5.91K | 1.03% | 30 |
|
|
2014
Q3 | $1.17M | Buy |
20,703
+36
| +0.2% | +$2.02K | 1.08% | 32 |
|
|
2014
Q2 | $1.14M | Buy |
20,667
+448
| +2% | +$24.4K | 1.01% | 33 |
|
|
2014
Q1 | $1.09M | Buy |
20,219
+177
| +0.9% | +$9.16K | 1.03% | 33 |
|
|
2013
Q4 | $957K | Buy |
+20,042
| New | +$916K | 0.88% | 39 |
|
Other funds holding MRK
VCM
VPM
Shoker Investment Counsel's MRK Position: Q1 2026 in Review
Shoker Investment Counsel reduced its Merck (MRK) stake by 3% in Q1 2026, selling an estimated $102K and leaving 28,572 shares worth $3.44M. The position accounts for 1.02% of the portfolio, ranked #24.
Shoker Investment Counsel first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.76M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Shoker Investment Counsel held 28,572 shares of Merck worth $3.44M as of Q1 2026.
- Shoker Investment Counsel sold 887 Merck shares in Q1 2026, an estimated $102K.
- Merck made up 1.02% of Shoker Investment Counsel's portfolio in Q1 2026, its #24 holding.
- Shoker Investment Counsel first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
- Shoker Investment Counsel's Merck position peaked at $3.76M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Shoker Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.